[Advances on treatment of small cell lung cancer with amrubicin].

作者信息

Lu Hongyang, Chen Lili, Cai Jufen, Ma Shenglin

机构信息

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China.

出版信息

Zhongguo Fei Ai Za Zhi. 2010 May;13(5):544-9. doi: 10.3779/j.issn.1009-3419.2010.05.30.

DOI:10.3779/j.issn.1009-3419.2010.05.30

PMID:20677657

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6000701/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f4b/6000701/cbe63a604246/zgfazz-13-5-544-1.jpg

相似文献

[Advances on treatment of small cell lung cancer with amrubicin].

Zhongguo Fei Ai Za Zhi. 2010 May;13(5):544-9. doi: 10.3779/j.issn.1009-3419.2010.05.30.

Small-cell lung cancer responds to amrubicin.

Lancet Oncol. 2007 Jan;8(1):13. doi: 10.1016/s1470-2045(06)70997-4.

Amrubicin for non-small-cell lung cancer and small-cell lung cancer.

Invest New Drugs. 2007 Oct;25(5):499-504. doi: 10.1007/s10637-007-9069-0. Epub 2007 Jul 13.

Thymic small cell carcinoma shows marked response to amrubicin.

J Thorac Oncol. 2009 Jun;4(6):778. doi: 10.1097/JTO.0b013e3181a52e74.

Amrubicin for the treatment of advanced lung cancer.

Expert Opin Drug Metab Toxicol. 2009 Feb;5(2):171-80. doi: 10.1517/17425250802670508.

Long-term amrubicin chemotherapy for small-cell lung cancer.

Anticancer Res. 2012 Apr;32(4):1423-7.

[A case of relapsed small-cell lung cancer successfully treated by administration of amrubicin].

Nihon Kokyuki Gakkai Zasshi. 2007 Dec;45(12):967-70.

[A case of small cell lung cancer under hemodialysis with chronic renal failure treated with amrubicin while measuring blood concentration of the drug].

Nihon Kokyuki Gakkai Zasshi. 2007 Apr;45(4):337-43.

Amrubicin monotherapy for elderly patients with previously treated lung cancer.

Intern Med. 2010;49(17):1857-62. doi: 10.2169/internalmedicine.49.3606. Epub 2010 Sep 1.

Amrubicin for the treatment of small cell lung cancer: does effectiveness cross the Pacific?

J Thorac Oncol. 2007 Feb;2(2):160-5. doi: 10.1097/jto.0b013e31802f1cd9.

引用本文的文献

Efficacy of weekly amrubicin for refractory or relapsed non-small cell lung cancer: A protocol of systematic review and meta-analysis.

Medicine (Baltimore). 2020 Jun 19;99(25):e20454. doi: 10.1097/MD.0000000000020454.

本文引用的文献

[Advance of treatment of small cell lung cancer in 2009 american society of clinical oncology annual meeting.].

Zhongguo Fei Ai Za Zhi. 2009 Sep 20;12(9):1047-50. doi: 10.3779/j.issn.1009-3419.2009.09.019.

Next-generation anthracycline for the management of small cell lung cancer: focus on amrubicin.

Drug Des Devel Ther. 2009 Feb 6;2:189-92. doi: 10.2147/dddt.s3972.

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer.

Lung Cancer. 2010 Jul;69(1):99-104. doi: 10.1016/j.lungcan.2009.09.012. Epub 2009 Oct 23.

A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405.

Ann Oncol. 2010 Apr;21(4):800-803. doi: 10.1093/annonc/mdp384. Epub 2009 Oct 13.

Amrubicin: a synthetic anthracyclin analogue in the treatment of extensive stage small cell lung cancer.

Recent Pat Anticancer Drug Discov. 2009 Nov;4(3):241-5. doi: 10.2174/157489209789206850.

A phase I study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.

J Thorac Oncol. 2009 Jun;4(6):741-5. doi: 10.1097/JTO.0b013e3181a52946.

Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancer.

Int J Clin Oncol. 2009 Feb;14(1):63-9. doi: 10.1007/s10147-008-0802-2. Epub 2009 Feb 20.

Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.

J Clin Oncol. 2008 Nov 20;26(33):5401-6. doi: 10.1200/JCO.2008.18.1974. Epub 2008 Oct 14.

Dose escalation study of amrubicin in combination with fixed-dose irinotecan in patients with extensive small-cell lung cancer.

Oncology. 2008;74(1-2):7-11. doi: 10.1159/000138350. Epub 2008 Jun 9.

Evaluation of the recommended dose and efficacy of amrubicin as second- and third-line chemotherapy for small cell lung cancer.

J Thorac Oncol. 2007 Aug;2(8):741-4. doi: 10.1097/JTO.0b013e31811f46f0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验